ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC18147-10mM (in 1mL DMSO) |
|
302-79-4 |
Tretinoin (Aberela)
|
0 | C20H28O2 | |
GC18147-50mg |
|
302-79-4 |
Tretinoin (Aberela)
|
0 | C20H28O2 | |
GC18146-50mg |
|
130152-35-1 |
(+)-Igmesine hydrochloride
|
0 | C23H29N.HCl | |
GC18146-10mg |
|
130152-35-1 |
(+)-Igmesine hydrochloride
|
0 | C23H29N.HCl | |
GC18145-1mg |
|
251293-28-4 |
Urotensin II (human)
|
0 | C64H85N13O18S2 | |
GC18144-50mg |
|
193022-04-7 |
CTS-1027
|
0 | C19H20ClNO6S | |
GC18144-10mg |
|
193022-04-7 |
CTS-1027
|
0 | C19H20ClNO6S | |
GC18144-5mg |
|
193022-04-7 |
CTS-1027
|
0 | C19H20ClNO6S | |
GC18142-50mg |
|
461000-66-8 |
Eact
|
0 | C22H24N2O5S | |
GC18142-10mg |
|
461000-66-8 |
Eact
|
0 | C22H24N2O5S | |
GC18141-100mg |
|
389614-94-2 |
EA4
|
0 | C19H17ClN2O2 | |
GC18141-50mg |
|
389614-94-2 |
EA4
|
0 | C19H17ClN2O2 | |
GC18141-10mg |
|
389614-94-2 |
EA4
|
0 | C19H17ClN2O2 | |
GC18141-5mg |
|
389614-94-2 |
EA4
|
0 | C19H17ClN2O2 | |
GC18140-10mM (in 1mL DMSO) |
|
415713-60-9 |
RI-1
|
0 | C14H11Cl3N2O3 | |
GC18140-50mg |
|
415713-60-9 |
RI-1
|
0 | C14H11Cl3N2O3 | |
GC18140-10mg |
|
415713-60-9 |
RI-1
|
0 | C14H11Cl3N2O3 | |
GC18140-5mg |
|
415713-60-9 |
RI-1
|
0 | C14H11Cl3N2O3 | |
GC18139-100mg |
|
103420-77-5 |
Devazepide
|
0 | C25H20N4O2 | |
GC18139-50mg |
|
103420-77-5 |
Devazepide
|
0 | C25H20N4O2 | |